References
- Forastiere A, Koch W, Trotti A et al : Head and neck cancer. N Engl J Med 345 : 1890, 2001 https://doi.org/10.1056/NEJMra001375
- Krammer PH, Behnnann I, Daniel P et al : Regulation of apoptosis in the immune system. Curr Biol 6 : 279, 1994 https://doi.org/10.1016/S0960-9822(02)00478-5
- Waddell WR, Ganser GF, Cerise EJ et al : Sulindac for polyposis of the colon. Am J Surg 157 : 175, 1989 https://doi.org/10.1016/0002-9610(89)90442-X
- Smalley WE, DuBois RN : Colorectal cancer and nonsteroidal anti-inflammatory drugs. Adv Pharmacol 39 : 1, 1997 https://doi.org/10.1016/S1054-3589(08)60067-8
- Williams CW, DuBois RN : Prostaglandin endoperoxide synthase : why two isoforms? Am J Physiol 270 : G393, 1996
- Masferrer JL, Zweifel BS, Manning PT et al : Selective inhibition of inducible cyclooxygenase-2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci USA 91(8) : 3228, 1994
- Simon LS : Actions and toxicity of nonsteroidal antiinflammatory drugs. Curr Opin Rheum 8 : 169, 1996 https://doi.org/10.1097/00002281-199605000-00001
-
Oshima M, Dinchuk JE, Kargman SL et al : Suppression of intestinal polyposis in Apc
$\Delta$ 716 knockout mice by inhibition of cyclooxygenase 2(COX-2). Cell 87 : 803, 1996 https://doi.org/10.1016/S0092-8674(00)81988-1 - Kawamori T, Rao CV, Seibert K et al : Chemopreventive activity of Celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 58 : 409, 1998
- Chan G, Boyle JO, Yang EK et al : Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 59 : 991, 1999
- Brown JR, DuBois RN : COX-2 : A molecular target for colorectal cancer prevention. J Clin Oncol 23 : 2840, 2005 https://doi.org/10.1200/JCO.2005.09.051
- Watanabe H, Saito H, Rychahou PG et al : Aging is associated with decreased pancreatic acinar cell regeneration and phosphatidylinositol 3-kinase/Akt activation. Gastroenterology 128(5) : 1391, 2005 https://doi.org/10.1053/j.gastro.2005.03.016
- Cheng JQ, Jiang X, Fraser M et al : Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer : possible involvement of the phosphoinositide-3 kinase/Akt pathway. Drug Resist Updat 5(3-4) : 131-46, 2002 https://doi.org/10.1016/S1368-7646(02)00003-1
- Neri LM, Borgatti P, Tazzari PL et al : The phosphoinositide 3-kinase/Akt1 pathway involvement in drug and alltrans-retinoic acid resistance of leukemia cells. Mol Cancer Res 1(3) : 234, 2003
- Paez J, Sellers WR : The PI3K/PTEN/Akt pathway : A critical mediator of oncogenic signaling. Cancer Treat Res 115 : 145, 2003
- Kaufmann SH, Earnshaw WC : Induction of apoptosis by cancer chemotherapy. Exp Cell Res 256(1) : 42, 2000 https://doi.org/10.1006/excr.2000.4838
- Susin SA, Lorenza HK, Zamzami N et al : Molecular chacterization of mitochondrial apoptosis-inducing factor. Nature 397 : 441, 1999 https://doi.org/10.1038/17135
- Crompton MB : Bid and the permeabilization of mitochondrial outer membrane in apoptosis. Curr Opin Cell Biol 12(4) : 414, 2000 https://doi.org/10.1016/S0955-0674(00)00110-1
- Li H, Zhu H, Xu C, et al : Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94(4) : 491, 1998 https://doi.org/10.1016/S0092-8674(00)81590-1
- Wieder T, Essmann F, Prokop A et al : Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3. Blood 97(5) : 1378, 2001 https://doi.org/10.1182/blood.V97.5.1378
- Vazquez F, Sellers WR : The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signalling. Biochem Biophys Acta 1470 : M21-M35, 2000
- Amir K, Agarwal HK : Role of COX-2 selective inhibitors for prevention and treatment of cancer. Pharmazie 60(8) : 563, 2005
- Park JS, Jun HJ, et al : Radiosensitivity enhancement by combined treatment of celecoxib and gefitinib on human lung cancer cells. Clin Cancer Res 12(16) : 4989, 2006 https://doi.org/10.1158/1078-0432.CCR-05-2259
-
Lev-Aris S, Kazanov D, Liberman E et al : Down-regulation of
$PGE_2$ by physiologic levels of celecoxib is not sufficient to induce apoptosis or inhibit cell proliferation in human colon carcinoma cell lines. Dig Dis Sci 52(4) : 1128, 2007 https://doi.org/10.1007/s10620-006-9619-x - Germain ME, Gagnon V, Mathieu I et al : Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells. Int J Oncol 24(5) : 1311, 2004
- Hsu Al, Ching TT, Wang DS et al : The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J Biol Chem 275(15) : 11397, 2000 https://doi.org/10.1074/jbc.275.15.11397
- Sawaoka H, Tsuji S, Tsujii M et al : Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab Invest 79(12) : 1469, 1999
- Barnes NL, Warnberg F, Farnie G et al : Cyclooxygenase-2 inhibition : effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer. Br J Cancer 96(4) : 575, 2007 https://doi.org/10.1038/sj.bjc.6603593
- Toyoshima T, Kamijo R, Ito D et al : Inhibitor of cyclooxygenase-2 induces cell-cycle arrest in the epithelial cancer cell line via up-regulation of cyclin dependent kinase inhibitor p21. Br. J Cancer 86(7) : 1150, 2002 https://doi.org/10.1038/sj.bjc.6600183
- Baek JY, Hur W, Wang JS et al : Selective COX-2 inhibitor, NS-398, suppresses cellular proliferation in human hepatocellular carcinoma cell lines via cell cycle arrest. World J Gastroenterol 13(8) : 1175, 2007 https://doi.org/10.3748/wjg.v13.i8.1175
- Dvory SH, Cohen NE, Kazanov D et al : Celecoxib leads to G2/M arrest by induction of p21 and down-regulation of cyclin B1 expression in a p53-independent manner. Eur J Cancer 42(3) : 422, 2006 https://doi.org/10.1016/j.ejca.2005.11.009
- Park C, Kim GY, Kim GD et al : Induction of G2/M arrest and inhibition of cyclooxygenase-2 activity by curcumin in human bladder cancer T24 cells. Oncol Rep 15(5) : 1225, 2006
- Bock JM, Menon SG, Sinclair LL et al : Celecoxib toxicity is cell cycle phase specific. Cancer Res 67(8) : 3801, 2007 https://doi.org/10.1158/0008-5472.CAN-06-3780
- Trifan OC, Smith Rm, Thompson BD et al : Overexpression of cyclooxygenase-2 induces cell cycle arrest. Evidence for a prostaglandin-independent mechanism. J Biol Chem 274(48) : 34141, 1999 https://doi.org/10.1074/jbc.274.48.34141
- Gilroy DW, Saunders MA, Wu KK : COX-2 expression and cell cycle progression in human fibroblasts. Am J Physiol Cell Physiol 281(1) : C188, 2001 https://doi.org/10.1152/ajpcell.2001.281.1.C188
- Ding H, Han C, Zhu J et al : Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9. Int J Cancer 113(5) : 803, 2005 https://doi.org/10.1002/ijc.20639
- Mattia C, Coluzzi F : COX-2 inhibitors : pharmacological data and adverse effects. Minerva Anestesiol 71(7-8) : 461, 2005
- Sooriakumaran P : COX-2 inhibitors and the heart: are all coxibs the same? Postgrad Med J 82(966) : 242, 2006 https://doi.org/10.1136/pgmj.2005.042234
- Chen LC, Ashcroft DM : Risk of myocardial infarction associated with selective COX-2 inhibitors : Meta-analysis of randomised controlled trials. Pharmacoepidermiol Drug Saf Apr, 2007
- Pyrko P, kardosh A, Liu YT et al : Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a noncoxib analogue of celecoxib. Mol Cancer Ther 6(4) : 1262, 2007 https://doi.org/10.1158/1535-7163.MCT-06-0629